Faith, Science, Ethics Roundtable for September

We begin the 2019-20 academic year at the Science, Ethics and Theology Roundtable with a continuation of our conversations about what constitutes human consciousness (what is it, where does it come from), and how it relates to the search for advances in medical and scientific research. 
 
The Roundtable will meet Monday, September 30th from 11:30am to 1pm in Room 117 of the Research Administration Bldg at the University of Utah
 
We are specifically looking at the studies being done by Dr. Roland Griffiths, a Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine, and founding Director of the Johns Hopkins Center on Psychedelic and Consciousness Research. His principal research focus in both clinical and preclinical laboratories has been on the behavioral and subjective effects of mood-altering drugs. His research has been largely supported by grants from the National Institute on Health and he is author of 380 journal articles and book chapters. He has been a consultant to the National Institutes of Health, to numerous pharmaceutical companies in the development of new psychotropic drugs, and as a member of the Expert Advisory Panel on Drug Dependence for the World Health Organization.
 
Please review as much of the linked information below as you like, in preparation for our conversation:

Johns Hopkins University opens new Center for Psychedelic and Consciousness Research
 
 
Is the Noumenon unknowable?  
 
The philosophy of Immanuel Kant addresses the divide between phenomenon, (what we subject to scientific research), with the "noumenon" (that which may exist beyond current scientific research). Is the new research center at Johns Hopkins beginning to bridge the divide?  Please visit the article below for an excellent overview of Kant's ideas on this:
 
 
Hopkins scientists show hallucinogen in mushrooms creates universal mystical experience
 
 
Commentary by Psychiatric community on Griffith's research:
 
 
Can psychedelic drugs help solve our mental health crisis?